Latest News in the pharma Industry

All

Pharma Explained:  Active Pharmaceutical Ingredients

Pharma Explained: Active Pharmaceutical Ingredients

11 Mar 2021

What are APIs? As the name suggests, Active Pharmaceutical Ingredients (APIs) are the heart of any dosage form, whether they are oral, injectable or inhaled, and are absolutely essential to the development of a formulated product.

Read more 
ANI Pharmaceuticals expands CDMO business through Novitium acquisition

ANI Pharmaceuticals expands CDMO business through Novitium acquisition

10 Mar 2021

The purchase will allow the company to add nine new customers to its growing CDMO business and 27 manufacturing suites

Read more 
Special Podcast: CPhI Outlook Roundtable - Listen Now

Special Podcast: CPhI Outlook Roundtable - Listen Now

9 Mar 2021

In this special roundtable podcast exploring potential opportunities in a post-vaccinated world, we are joined by a panel of three world class experts – Bikash Chatterjee, CEO of Pharmatech Associates; Parrish Galliher, Managing Director, Bi...

Read more 
Clinical Development Success Rates and Contributing Factors 2011-2020: New Report from Informa Pharma Intelligence

Clinical Development Success Rates and Contributing Factors 2011-2020: New Report from Informa Pharma Intelligence

9 Mar 2021

Biologic products advance through clinical development with a higher success rate than traditional small molecules, this new analysis of clinical development success from Informa Pharma Intelligence, the Biotechnology Industry Organization and the...

Read more 
Inhalation specialist Vectura invests to expand manufacturing capabilities

Inhalation specialist Vectura invests to expand manufacturing capabilities

9 Mar 2021

The enhancements will include installing the lever-operated multi-dose inhaler device used in Hikma’s generic Advair product, which the FDA recently approved

Read more 
CPhI post-pandemic report forecasts explosion of contract services growth

CPhI post-pandemic report forecasts explosion of contract services growth

9 Mar 2021

During the next 12 months, demand for early-stage contract projects could quickly exceed supply

Read more 
Lonza to develop and manufacture Ixogen's oncolytic virus

Lonza to develop and manufacture Ixogen's oncolytic virus

8 Mar 2021

PsiVac has generated compelling efficacy data in killing a broad range of tumour cells, including head and neck, bladder, liver, pancreatic and ovarian

Read more 
Vetter opens Chinese office to support promising injectable pipeline

Vetter opens Chinese office to support promising injectable pipeline

8 Mar 2021

The strategic move will enable the injectables CDMO to support domestic companies that plan on bringing their molecules to the global market

Read more 
CPhI Monthly Podcast: Decentralised Clinical Trial Design - Collecting Real World Data in a Remote Setting

CPhI Monthly Podcast: Decentralised Clinical Trial Design - Collecting Real World Data in a Remote Setting

4 Mar 2021

In this podcast interview with Fabien Du Fraisse and Deepu Joseph at Quanticate, we delve into the trend of decentralising clinical trials 

Read more 
Merck agrees to support Johnson & Johnson in vaccine manufacturing deal

Merck agrees to support Johnson & Johnson in vaccine manufacturing deal

3 Mar 2021

Funding from BARDA helps the company to adapt and make available a number of existing manufacturing facilities for the production of SARS-CoV-2 vaccines and medicines

Read more 
WuXi AppTec completes $135 million acquisition of Oxgene

WuXi AppTec completes $135 million acquisition of Oxgene

2 Mar 2021

The addition further strengthens WuXi's cell and gene therapy service offerings for global customers and will be Wuxi ATU's first facility in Europe

Read more 
WEBINAR: Driving Digital Transformation in Pharma – Watch Now!

WEBINAR: Driving Digital Transformation in Pharma – Watch Now!

1 Mar 2021

Watch this recent webinar which looks at how pharma is partnering with digital tech companies in order to find market-based solutions to current issues and take advantage of the larger volumes of data now available

Read more